Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17


Clearance of attenuated rabies virus from brain tissues is required for long-term protection against CNS challenge with a pathogenic variant.

Garcia SA, Lebrun A, Kean RB, Craig Hooper D.

J Neurovirol. 2018 Oct;24(5):606-615. doi: 10.1007/s13365-018-0655-z. Epub 2018 Jul 9.


Exosomal αvβ6 integrin is required for monocyte M2 polarization in prostate cancer.

Lu H, Bowler N, Harshyne LA, Craig Hooper D, Krishn SR, Kurtoglu S, Fedele C, Liu Q, Tang HY, Kossenkov AV, Kelly WK, Wang K, Kean RB, Weinreb PH, Yu L, Dutta A, Fortina P, Ertel A, Stanczak M, Forsberg F, Gabrilovich DI, Speicher DW, Altieri DC, Languino LR.

Matrix Biol. 2018 Sep;70:20-35. doi: 10.1016/j.matbio.2018.03.009. Epub 2018 Mar 9.


Protection Against CNS-Targeted Rabies Virus Infection is Dependent upon Type-1 Immune Mechanisms Induced by Live-Attenuated Rabies Vaccines.

Lebrun A, Garcia S, Li J, Kean RB, Hooper DC.

Trop Med Infect Dis. 2017 Jul 4;2(3). pii: E22. doi: 10.3390/tropicalmed2030022.


T-bet Is Required for the Rapid Clearance of Attenuated Rabies Virus from Central Nervous System Tissue.

Lebrun A, Portocarrero C, Kean RB, Barkhouse DA, Faber M, Hooper DC.

J Immunol. 2015 Nov 1;195(9):4358-68. doi: 10.4049/jimmunol.1501274. Epub 2015 Sep 25.


Intramuscular inoculation of mice with the live-attenuated recombinant rabies virus TriGAS results in a transient infection of the draining lymph nodes and a robust, long-lasting protective immune response against rabies.

Schutsky K, Curtis D, Bongiorno EK, Barkhouse DA, Kean RB, Dietzschold B, Hooper DC, Faber M.

J Virol. 2013 Feb;87(3):1834-41. doi: 10.1128/JVI.02589-12. Epub 2012 Nov 28.


Therapeutic immune clearance of rabies virus from the CNS.

Hooper DC, Roy A, Kean RB, Phares TW, Barkhouse DA.

Future Virol. 2011 Mar 1;6(3):387-397.


Rabies virus clearance from the central nervous system.

Hooper DC, Roy A, Barkhouse DA, Li J, Kean RB.

Adv Virus Res. 2011;79:55-71. doi: 10.1016/B978-0-12-387040-7.00004-4. Review.


Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus.

Faber M, Li J, Kean RB, Hooper DC, Alugupalli KR, Dietzschold B.

Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11300-5. doi: 10.1073/pnas.0905640106. Epub 2009 Jul 6.


Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity.

Fabis MJ, Phares TW, Kean RB, Koprowski H, Hooper DC.

Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15511-6. doi: 10.1073/pnas.0807656105. Epub 2008 Sep 30.


Early blood-brain barrier permeability in cerebella of PLSJL mice immunized with myelin basic protein.

Spitsin S, Portocarrero C, Phares TW, Kean RB, Brimer CM, Koprowski H, Hooper DC.

J Neuroimmunol. 2008 May 30;196(1-2):8-15. doi: 10.1016/j.jneuroim.2008.02.004. Epub 2008 Apr 11.


Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models.

Fabis MJ, Scott GS, Kean RB, Koprowski H, Hooper DC.

Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5656-61. Epub 2007 Mar 19.


ICAM-1 upregulation in the spinal cords of PLSJL mice with experimental allergic encephalomyelitis is dependent upon TNF-alpha production triggered by the loss of blood-brain barrier integrity.

Scott GS, Kean RB, Fabis MJ, Mikheeva T, Brimer CM, Phares TW, Spitsin SV, Hooper DC.

J Neuroimmunol. 2004 Oct;155(1-2):32-42.


Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors.

Scott GS, Spitsin SV, Kean RB, Mikheeva T, Koprowski H, Hooper DC.

Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16303-8. Epub 2002 Nov 25.


Comparison of uric acid and ascorbic acid in protection against EAE.

Spitsin SV, Scott GS, Mikheeva T, Zborek A, Kean RB, Brimer CM, Koprowski H, Hooper DC.

Free Radic Biol Med. 2002 Nov 15;33(10):1363-71.


Supplemental Content

Loading ...
Support Center